James Cancer Hospital and Solove Research Institute (Site 119) — Columbus, Ohio

James Cancer Hospital and Solove Research Institute (Site 119) is a clinical research site located in Columbus, Ohio, United States 43219.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

James Cancer Hospital and Solove Research Institute (Site 119) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC).

Sponsors: J-Pharma Co., Ltd..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for James Cancer Hospital and Solove Research Institute (Site 119)?

James Cancer Hospital and Solove Research Institute (Site 119) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has James Cancer Hospital and Solove Research Institute (Site 119) conducted?

James Cancer Hospital and Solove Research Institute (Site 119) has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC).

Is James Cancer Hospital and Solove Research Institute (Site 119) accredited by Crixeo Health?

James Cancer Hospital and Solove Research Institute (Site 119) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about James Cancer Hospital and Solove Research Institute (Site 119)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.